Kenaday Medical Clinic is categorized under Clinics in Tampa, FL and active since 2002.
Kenaday Medical Clinic was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Kenneth Shobola at the company’s single location by writing to 8001 North Dale Mabry Highway # 801a, Tampa, Florida FL 33614 or by phoning (813) 402-2891. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Kenaday Medical Clinic |
| Contact Person: | Kenneth Shobola |
| Address: | 8001 North Dale Mabry Highway # 801a, Tampa, Florida 33614 |
| Phone Number: | (813) 402-2891 |
| Website Address: | kenadaymedical.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Kenaday Medical Clinic was started in 2002 to provide professional Clinics under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Kenneth Shobola for inquiries that concern Kenaday Medical Clinic by calling the company number (813) 402-2891, as your correspondence is most welcome. Additionally, the physical location of the single location of Kenaday Medical Clinic can be found at the coordinates 28.020934,-82.504961 as well as the street address 8001 North Dale Mabry Highway # 801a in Tampa, Florida 33614.
For its online presence, you may visit Kenaday Medical Clinic’s website at kenadaymedical.com and engage with its social media outlets through on Twitter and on Facebook.